| Literature DB >> 31067744 |
Jesper Fogelholm1, Samuel Inkabi2, Andrey Höglund3, Robin Abbey-Lee4, Martin Johnsson5,6, Per Jensen7, Rie Henriksen8, Dominic Wright9.
Abstract
Identifying the molecular mechanisms of animal behaviour is an enduring goal for researchers. Gaining insight into these mechanisms enables us to gain a greater understanding of behaviour and their genetic control. In this paper, we perform Quantitative Trait Loci (QTL) mapping of tonic immobility behaviour in an advanced intercross line between wild and domestic chickens. Genes located within the QTL interval were further investigated using global expression QTL (eQTL) mapping from hypothalamus tissue, as well as causality analysis. This identified five candidate genes, with the genes PRDX4 and ACOT9 emerging as the best supported candidates. In addition, we also investigated the connection between tonic immobility, meat pH and struggling behaviour, as the two candidate genes PRDX4 and ACOT9 have previously been implicated in controlling muscle pH at slaughter. We did not find any phenotypic correlations between tonic immobility, struggling behaviour and muscle pH in a smaller additional cohort, despite these behaviours being repeatable within-test.Entities:
Keywords: QTL; behaviour; domestication; eQTL; muscle pH; tonic immobility
Mesh:
Year: 2019 PMID: 31067744 PMCID: PMC6562468 DOI: 10.3390/genes10050341
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Tonic Immobility (TI) quantitative trait loci (QTL) identified in the main mapping population. Chromosome, position (in cM and chr:bp), additive and dominance effects, lower and upper confidence intervals (CI), as well as covariates used and any epistatic interactions incorporated are provided, as is the total variance explained by each QTL (r-squared) and the nearest genetic marker to the upper and lower C.I. Traits are maximum time spent in tonic immobility (TI maximum d.), average time spent in tonic immobility (TI average d.), time spent in tonic immobility in trial 1 (TI duration 1) and time spent in tonic immobility in trial 2 (TI duration 2).
| Trait | Chr | Position | LOD | Add ± S.E. | Dom ±S.E. | Lower CI | Upper CI | Lower Marker | Position (Chr:bp) | Upper Marker | Position (Chr:bp) | Covariates | Interaction |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TI maximum d. | 1 | 2014 | 5.8 | −19.9 ± 21.6 | −25.7± 42.1 | 1991 | 2038 | 1_190334672 | 1:190334672 | 1_195271649 | 1:195271649 | sex, batch, PC2,3,10 | 1@2014.0:2@485.0 | 3.7 |
| TI duration 2 | 1 | 1750 | 7.3 | −30.8 ± 11.7 | −2.0 ± 15.4 | 1735 | 1756 | Gg_rs10728648 | 1:144081810 | snp-23-342-18608-S-2 | 1:151495059 | sex, batch, PC2,6 | 1@1748.0:7@3.0 | 5 |
| TI average d. | 2 | 774 | 6.5 | −10.8 ± 9.2 | −28.7± 14 | 764 | 795 | RBL1120 | 2:116617839 | Gg_rs15146557 | 2:117659953 | sex, batch, PC2,6 | 2@774.0:24@60.7 | 4.6 |
| TI maximum d. | 2 | 485 | 7.3 | 27.9 ± 13.1 | −3.3 ± 17 | 474 | 495 | Gg_rs14190959 | 2:60361704 | Gg_rs15110213 | 2:65012153 | sex, batch, PC2,3,10 | 1@2014.0:2@485.0 | 4.7 |
| TI maximum d. | 2 | 775 | 7.3 | −9.9 ± 12.8 | −18.1± 19.3 | 767 | 798 | RBL1120 | 2:116617839 | Gg_rs15146557 | 2:117659953 | sex, batch, PC2,3,10 | 2@775.0:24@61.0 | 4.7 |
| TI duration 2 | 2 | 181 | 7.9 | −63.0 ± 14.9 | −35.7± 18.3 | 170 | 195 | Gg_rs15070042 | 2:19473457 | 2_23979784 | 2:23979784 | sex, batch, PC2,6 | 24@60.7:2@181.0 | 5.2 |
| TI duration 1 | 4 | 283 | 9.7 | 33.4 ± 10.5 | 11.4 ± 16.2 | 272 | 292 | Gg_rs14446625 | 4:31963411 | 4_37860292 | 4:37860292 | sex, batch, PC1,4 | 4@283.0:15@187.9 | 7.8 |
| TI duration 1 | 6 | 259 | 6.9 | 5.6 ± 9.1 | 10.7 ± 12.2 | 247 | 270 | 6_25762392 | 6:25762392 | Gg_rs14592224 | 6:30433595 | sex, batch, PC1,4 | 6@258.7:10@185.0 | 5.5 |
| TI duration 2 | 7 | 4 | 11.5 | 11.2 ± 13.5 | 48.5 ± 17.7 | 0 | 8 | Gg_rs15826188 | 7:1654910 | Gg_rs15828492 | 7:2444843 | sex, batch, PC2,6 | 1@1748.0:7@3.0, 7@3.0:24@60.7 | 7.8 |
| TI average d. | 10 | 99 | 5.9 | −15.1 ± 7.7 | 14.9 ± 10.1 | 86 | 109 | Gg_rs14941656 | 10:2678686 | Gg_rs14003134 | 10:5805005 | sex, batch, PC2,6 | 10@99.0:20@247.7 | 4.1 |
| TI maximum d. | 10 | 139 | 8.4 | −24 ± 11.4 | −35.5 ± 15.1 | 133 | 144 | 10_9525779 | 10:9525779 | Gg_rs14947769 | 10:11621480 | sex, batch, PC2,3,10 | 10@139.0:12@85.0 | 5.4 |
| TI duration 1 | 10 | 185 | 8.5 | 2.4 ± 9.5 | −34.6± 12.2 | 176 | 198 | Gg_rs14008254 | 10:12705455 | GG_rs14951592 | 10:15605204 | sex, batch, PC1,4 | 6@258.7:10@185.0 | 6.8 |
| TI maximum d. | 12 | 85 | 7.2 | −24.2 ± 11.5 | 8.7 ± 14.7 | 77 | 190 | Gg_rs13609494 | 12:5140626 | 12_14051161 | 12:14051161 | sex, batch, PC2,3,10 | 10@139.0:12@85.0 | 4.7 |
| TI duration 1 | 15 | 188 | 7.9 | −18.0 ± 9.6 | −19.5± 12.3 | 177 | 189 | Gg_rs14095161 | 15:10467522 | Gg_rs14095923 | 15:11490734 | sex, batch, PC1,4 | 4@283.0:15@187.9 | 6.3 |
| TI average d. | 20 | 247.7 | 6.4 | −9.4 ± 7.1 | 24 ± 10.1 | 237 | 252 | Gg_rs15177950 | 20:10931547 | Gg_rs14280872 | 20:13367853 | sex, batch, PC2,6 | 10@99.0:20@247.7 | 4.8 |
| TI average d. | 24 | 60.7 | 7 | −20.9 ± 8.5 | −21.0± 11 | 53 | 67 | GG_rs16194400 | 24:1782119 | Gg_rs14294768 | 24:3003659 | sex, batch, PC2,6 | 2@774.0:24@60.7 | 4.9 |
| TI maximum d. | 24 | 61 | 8.7 | −26.6 ± 11.9 | −25.0 ± 15.4 | 54 | 66 | GG_rs16194400 | 24:1782119 | Gg_rs14294768 | 24:3003659 | sex, batch, PC2,3,10 | 2@775.0:24@61.0 | 5.6 |
| TI duration 2 | 24 | 61 | 16.5 | 21.5 ± 15.3 | −40.9 ± 18.7 | 54 | 65 | GG_rs16194400 | 24:1782119 | Gg_rs14294768 | 24:3003659 | sex, batch, PC2,6 | 7@3.0:24@60.7, 24@60.7:2@181.0 | 11.5 |
Causality analysis of the candidate genes in the eQTL sub-population of the F8 mapping population. Gene and probe name (in the microarray) are provided, as are the eQTL chromosomal location and position in cM. The p-value of the correlation with the behavioural trait, as well as which behavioural trait is also included. The QTL effect of the behaviour specifically in the eQTL sub-population is included, to allow the behavioural QTL strength of effect in this smaller sub-population to be assessed (* p < 0.05, ** p < 0.01, *** p < 0.001). Where two values are given the first is the significance of the behavioural QTL with just the single marker effect, the second is with the two marker epistatic interaction detected in the full sample included. Causality metrics leo.nb.oca and leo.nb.cpa measures are used to assess the strength of causality, with leo.nb.cpa values used when eQTL and QTL share the same genetic marker and leo.nb.oca values are used when eQTL and behavioural QTL have separate markers.
| Gene | Probe Name | eQTL Chr | eQTL Position | eQTL LOD | Behaviour Trait | Behavioural Trait Correlation | Behavioural Trait | Behaviour QTL LOD | Behaviour QTL chr | Behaviour QTL Position | LEO.NB.OCA | LEO.NB.CPA | NEO Model |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ENSGALT00000026377_Q5F3B4_CHICK | 10 | 138 | 8.6*** | TI maximum d. | 0.004 | 2.9 | 0.8/5.9*** | 10 | 139 | - | 0.50 | 0.88 |
|
| ENSGALT00000026377_Q5F3B4_CHICK | 10 | 138 | 8.6*** | TI maximum d. | 0.004 | 2.9 | 1.5*/6.6*** | 12 | 85 | 0.12 | 0.50 | 0.99 |
|
| ENSGALT00000036634_Q5F3B4_CHICK | 10 | 128 | 7.1*** | TI maximum d. | 0.02 | 2.3 | 0.8/5.9*** | 10 | 139 | - | 0.55 | 0.98 |
|
| ENSGALT00000036634_Q5F3B4_CHICK | 10 | 128 | 7.1*** | TI maximum d. | 0.02 | 2.3 | 1.5*/6.6*** | 12 | 85 | 0.15 | 0.55 | 0.94 |
|
| 603865613F1 | 2 | 778 | 6.7*** | TI average d. | 0.017 | −2.4 | 1.4* | 2 | 774 | - | 0.49 | 0.38 |
|
| 603865613F1 | 2 | 778 | 6.7*** | TI maximum d. | 0.02 | −2.4 | 2.2** | 2 | 775 | - | 0.31 | 0.20 |
|
| 603863179F1 | 2 | 784 | 6.1*** | TI average d. | 0.03 | −2.1 | 1.4* | 2 | 774 | 0.05 | 0.03 | <0.001 |
|
| 603863179F1 | 2 | 784 | 6.1*** | TI maximum d. | 0.03 | −2.1 | 2.2** | 2 | 775 | - | −0.30 | <0.001 |
|
| ENSGALT00000025015_LOC771318 | 2 | 784 | 6.6*** | TI average d. | 0.03 | 2.1 | 1.4* | 2 | 774 | 0.04 | 0.31 | <0.001 |
|
| ENSGALT00000025015_LOC771318 | 2 | 784 | 6.6*** | TI maximum d. | 0.03 | 2.1 | 2.2** | 2 | 775 | - | −0.38 | <0.001 |
|
| ENSGALT00000026387_PRDX4 | 10 | 138.7 | 8.5*** | TI maximum d. | 0.0002 | 3.9 | 0.8/5.9*** | 10 | 139 | - | 0.38 | 0.66 |
|
| ENSGALT00000026387_PRDX4 | 10 | 138.7 | 8.5*** | TI maximum d. | 0.0002 | 3.9 | 1.5*/6.6*** | 12 | 85 | 0.11 | 0.38 | 0.96 |
|
| 603867427F1 | 24 | 67 | 6.6*** | TI duration 2 | 0.004 | −3.0 | 1.0 N.S. | 24 | 61 | - | - | - |
Partial Spearman’s correlations (controlling for sex) for tonic immobility, inverted restraint and muscle pH in the F13 verification cohort. Numbers above the diagonal show the p-value significance of each pairwise correlation (*p < 0.05, **p < 0.01, ***p < 0.001), whilst numbers below the diagonal are the Rho correlation coefficient.
| Combined Data (Male and Female) | Initial Restraint Test | Pre-Slaughter Restraint | Tonic Immobility | pH | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Duration | No. Flaps | Duration | No. Flaps | Duration 1 | Duration 2 | Average d. | Maximum d. | Initial | >5h pH | ||
| Initial restraint test | duration | - | <0.001*** | 0.33 | 0.53 | 0.38 | 0.58 | 0.82 | 0.74 | 0.39 | 0.40 |
| no. flaps | 0.98 | - | 0.43 | 0.70 | 0.27 | 0.74 | 0.66 | 0.59 | 0.43 | 0.46 | |
| Pre-slaughter restraint | duration | 0.15 | 0.12 | - | <0.001*** | 0.60 | 0.85 | 0.84 | 0.77 | 0.87 | 0.21 |
| no. flaps | 0.10 | 0.06 | 0.94 | - | 0.96 | 0.95 | 0.78 | 0.45 | 0.98 | 0.43 | |
| Tonic immobility | duration 1 | 0.14 | 0.17 | 0.08 | 0.01 | - | <0.005** | <0.001*** | <0.001*** | 0.96 | 0.68 |
| duration 2 | −0.09 | −0.05 | 0.03 | −0.01 | 0.43 | - | <0.001*** | <0.001*** | 0.56 | 0.72 | |
| average d. | 0.04 | 0.07 | 0.03 | −0.04 | 0.83 | 0.83 | - | <0.001*** | 0.77 | 0.68 | |
| maximum d. | 0.05 | 0.09 | −0.05 | −0.12 | 0.81 | 0.74 | 0.95 | - | 0.70 | 0.87 | |
| pH | initial | 0.13 | 0.12 | 0.03 | 0.00 | −0.01 | 0.09 | 0.05 | 0.06 | - | <0.005** |
| >5h pH | 0.13 | 0.11 | 0.19 | 0.12 | 0.06 | 0.06 | 0.06 | 0.03 | 0.42 | - | |